“De novo” Appearance of a Choroidal Melanoma During 5 Yearsʼ Follow-up for CHRPE

Basile Salmon; Ann Schalenbourg

doi:10.1055/a-1785-5349

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2022; 239(04): 590-592
DOI: 10.1055/a-1785-5349

Der interessante Fall

“De novo” Appearance of a Choroidal Melanoma During 5 Yearsʼ Follow-up for CHRPE

„De-novo“-Erscheinen eines Aderhautmelanoms während des 5-Jahres-Follow-ups einer kongenitalen Hypertrophie des retinalen Pigmentepithels

Basile Salmon

Ophthalmology, Hôpital ophtalmique Jules-Gonin, University of Lausanne, Lausanne, Switzerland

,

Ann Schalenbourg

Ophthalmology, Hôpital ophtalmique Jules-Gonin, University of Lausanne, Lausanne, Switzerland

References
1 Scotto J, Fraumeni Jr JF, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst 1976; 56: 489-491
2 Toro MD, Gozzo L, Tracia L. et al. New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review. Biomedicines 2021; 9: 1311
3 Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea: II. Relationship of uveal nevi to malignant melanoma. Cancer 1967; 20: 493-507
4 Albert DM, Lahav M, Packer S. et al. Histogenesis of malignant melanomas of the uvea: occurrence of nevus-like structures in experimental choroidal tumors. Arch Ophthalmol 1974; 93: 318-323
5 Shields CL, Dalvin LA, Ancona-Lezama D. et al. Choroidal nevus imaging features in 3806 cases and risk factors for transformation into melanoma in 2355 cases. Retina 2019; 39: 1840-1851
6 Roelofs KA, OʼDay R, Harby LA. et al. The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?. Cancers (Basel) 2020; 12: 1311
7 Sahel JA, Pesavento R, Frederick jr. AR. et al. Melanoma arising de novo over a 16-month period. Arch Ophthalmol 1988; 106: 381-385
8 Aleksidze N, Medina CA, Singh AD. De novo evolution of a small choroidal melanoma. Ocul Oncol Pathol 2015; 1: 83-87
9 Augsburger JJ, Gonder JR, Amsel J. et al. Growth rates and doubling times of posterior uveal melanomas. Ophthalmology 1984; 91: 1709-1715
10 Moulin AP, Zografos L, Schalenbourg A. RPE adenocarcinoma arising from a congenital hypertrophy of the RPE (CHRPE) treated with proton therapy. Klin Monbl Augenheilkd 2014; 231: 411-413
11 Geiger F, Said S, Bajka A. et al. Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging–A Retrospective Chart Review. Curr Oncol 2022; 29: 1018-1028